₦airaland Forum

$ACHV did a reverse stock split of 20:1 today. Just seeing that my 300 shares bought today are now 15, while share price was adjusted from $0.70 to $14.

$ACHV seems to be sitting on a goldmine, based on
successful topline results from the Phase III "non-inferiority" clinical trial comparing its drug (Cytisinicline) to Pfizer's drug (Chantix) used for smoking cessation.

Pfizer had monopolized the smoking cesation industry where it makes over $2 Billion in annual revenue.

Increased my stake in Apple ($APPL) today. Also, targeting the drop in price, after the 4:1 stock split to accumulate more. Long term play here. Besides, "an apple a day, keeps the Doctor away"

Electrocore ($ECOR) ready to soar after the US FDA issued "Emergency Use Authorization" allowing for the use of its gammaCore Sapphire™ CV product to treat elderly people with covid-19 respiratory symptoms. It's up 75%+ premarket.
As always, DD is required.

Bonne chance!!!

Excellent 2Q2020 earnings from Amazon ($AMZN):
- Net Sales: $88.9B (expected $81.24B)
- EPS: $10.30 (exp. $1.46)
- Sees 3Q Net Sales btw $87.0B - $93.0B (exp. $86.51B)
- Coy created over 175,000 new jobs since March 2020

Keinding:
Ah! You beat me to it. Impressive from Amazon (10x)
On the bold, good news to some, bad to others, neutral to the watchers.... What side of the divide are you?

No be small thing o. $PRPO only announced the commercial launch of its corona virus antibody test and the market went crazy, valuing its stock beyond its current earnings.

sonnie10:
Bros run with your 20%. Health stocks are crazy

Precipio ($PRPO) has skyrocketed by 350%+ today alone. Just managed to buy Afolabi units few minutes ago and i'm up 20%. JIJO for me here.

$JMIA is up 15% today. Still room to surge, if upcoming earnings beat the market. I'm currently at 30% since I bought $JMIA shares.

Pulled the trigger on $BLNK when market opened today and it's already up 48%.

Jayjaycee18:
Currently tracking $BLNK (mid term) and the following short term/speculative stocks $ONTX, $INPX and $ACHV. Would pull the trigger once there's a pullback.
As always, DD is required before investing in any stock.

Bonne chance!!!

InaNla:
Great efforts. I am here once you are ready to strike. Don’t forget to let me know... DD have been done

Currently tracking $BLNK (mid term) and the following short term/speculative stocks $ONTX, $INPX and $ACHV. Would pull the trigger once there's a pullback.
As always, DD is required before investing in any stock.

Bonne chance!!!

$AZN 2Q2020 earnings

-Revenue: $6.28B (estimate $6.28B)
-Core EPS: 96C (est. 93C)
-Farxiga drug Revenue: $443M (est $436.6M)
-Tagrisso drug Rev: $1.03B (est $1.02B)
-Interim div/share: 90C
-Retains FY Guidance

N.B: This stock is grossly undervalued, churns out profit and regularly pays dividend. However, I have observed that sentiments in US markets don't seem to favour most foreign stocks and that's why prices of stocks like $AZN, $BABA et al are lagging their US counterparts.

You're welcome. Glad to interact with like-minded and stock investment savvy folks here. Sharing and learning from each other on this forum, always makes my day. Much props to @OakPearl for kick-starting this forum.

I currently own 16 stocks in my portfolio, consisting of 2 "very long-term" outlook stocks, 4 long-term, 7 mid-term and 3 short-term stocks. Looking to prune this number to a maximum of 10 by adding to my established winners and selling off the laggards and those where my targets have been met.

OvaSabi1:
Thank you for your time and for your reply. Can I ask how many stocks you maintain in your portfolio on average? How many companies' stocks do you own? If you don't want to disclose, no problem.

Sogou ($SOGO) shares are flying after the company received a preliminary non-binding acquisition offer from Tencent at $9 per share in cash. Great deal for the company and its shareholders.

Also, market insiders are speculating that Moderna ($MRNA) would bid between $10-$15 for $ABUS (Arbutus Biopharma). Recall that on Friday, July 24, $ABUS won the law suit on the patent that $MRNA is allegedly using to develop its covid-19 vaccine.

OakPearl:
STOCK TO WATCH SOGO $8.54

SOGO the Chinese version of Google has been firing on all cylinders.
It rose to $5 on Friday and I thought I should wait for a dip, but there it is still tearing with a 48% gain today!

Nice one. I often read Jim Cramer's posts but haven't read any of Dave Ramsey's posts. Actually, my stock investments are split into short-term, mid-term, long-term and very long-term.

For very long term, i try to buy company's that are recovering from crises, undergoing recapitalization, lower or close to its 52weeks low, and was hitherto very profitable and paying annual dividend. Currently tracking Just Energy ($JE), a Canadian-based coy focused on essential needs (i.e. a water quality, natural gas, electricity retailer) operating in Canadian and American markets across North America, and in Germany, Ireland and Japan.

In the last 11years of operation (2009 - 2019), $JE consistently paid an average annual dividend of $0.50 (lowest of $0.25 in 2019 and highest of $1.24 in 2011) before the business made losses in 2019. JE recently exited the loss making countries like Ireland, Japan and Germany in order to focus on North America, where they are more profitable and also announced recapitalization plans which started this July to end in Sept 2020.

JE's current price is $0.41 with 52-weeks low of $0.34 and 52-weeks high of $3.64. It's all-time highest stock closing price was $16.32 on April 01, 2011.

Disclosure: I bought at $0.41 and ready to hold for very long time, possibly 5-10 years until my price target is met, before i offload. This is still a risky bet. As usual, DD is required before investing in any stock.

Bonne chance!!!

OvaSabi1:
I am wondering if there's anyone here who is strictly long term investing? Or considering it? Are we allowed to post links to other social media here? Not mine. I will like you guys (who are considering moving from day trading to long term investing) to watch and read some materials from Jim Cramer and Dave Ramsey.

Way to go. I'm pulling the trigger anywhere between $1,700 and $1,800, depending on market reaction to its 2Q2020 earnings report. I'm certainly not waiting for it to get to $2,000. Tesla is highly volatile and one can always buy lower at price dips.

OakPearl:
If you hit your target price of $1,700 and sell, you are never wrong even if it goes past it after you sell.

That said, on the back of a good result for a stock that enjoys public sentiment as Tesla, you may wanna watch to ride higher than $1,700 before selling at a peak to return at a dip as planned.
Either way, it's a win/win.

Advanced Micro Devices ($AMD) seems undervalued at current price or below. From 3Q2020, HP and Lenovo will start including AMD processors in their new PCs.

Also, AMD has gained market share from INTELS and NVIDIA and it's making new chips to serve both the Server (for NVIDIA et al) and Gaming industries (i.e. the new Xbox Series X and PlayStation 5). Besides, demand in the Gaming industry has been boosted by the covid-19 lockdown.

I'm long on this one and got in yesterday ahead of its 2Q2020 earnings report on July 28.
As always, DD is required.

Bonne chance!!!.

$JMIA exited both Cameroon and Tanzania in November 2019.

OvaSabi1:
When did the exit happen?

Jumia ($JMIA) currently on 15% price gain today. They exited the loss making African markets in order to focus on Nigeria and other markets.

I expect this $AZN price dip to be temporal. Apart from the covid-19 vaccine trials, $AZN has many drugs in its pipeline, including vital lung cancer and oncology treatments that are high revenue earners globally.

Skymoore1004:
$AZN is really pissing me off

The market seems to be weary of pharmaceutical stocks amidst the endless drama of Covid-19 vaccine trials. There wasn't a surge in $AZN's price, in spite of its very promising vaccine trial result. Pfizer ($PFE) has a very good dividend yield and its a good stock to have in a portfolio. Not sure if this news would make it fly, but $PFE is expected to beat earnings estimates when 2Q2020 report is released on July 28, which may propel the stock on a sustained bullish run.
As always, DD is required.

Bonne chance!!!

afroxyz:
Choi! This one na village people abi na wetin? Wanted to get into PFE last week as I was taking position in BNTX. Good entry point, but when I looked at the three month performance, the stock is a slow mover like JNJ. Now this. Would take up position when the selling frenzy hits the market when it opens.

What do you guys think?

https://www.cnbc.com/2020/07/22/us-government-taps-pfizer-to-produce-millions-of-doses-of-coronavirus-vaccine.html?__source=androidappshare

This stock, $ACOR seems to be on steroids. Already surged 12.24% to $0.92 in early hours of trading today. Still a very risky bet.

Jayjaycee18:
Penny Stock Alert!!!
Acorda Therapeutics ($ACOR) has surged about 10.5% since market opened today after it was granted patent on methods invented "for cardiomyocyte treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid".

This was a good but risky bet for day trading. Went in on huge volumes at $0.74 and jumped out at $0.81. JIJO (jump in & jump out) trading for me on this one.
Not a recommendation to buy. DD required as usual.

Bonne chance!!!

Stock Analysis: Twitter ($TWTR)

From Techincal analysis, $TWTR has formed a 'golden cross' on its daily price chart, with the 50-day SMA ($32.88) line crossing above the 200-day SMA ($31.87) line. While a golden cross typically signifies a technically bullish phase and buy signal, the recent incident where the Twitter accounts of prominent folks like Biden, Obama et al were hacked, could potentially impede any potential price bull run. Another concern is that the golden cross on $TWTR's chart was formed with reducing daily volumes traded, instead of increasing daily traded volumes of its shares.

Hence, no investment decision is recommended at this time, until $TWTR's upcoming 2Q2020 earnings report on July 23, which should give traders a clearer picture to determine if the share price is undervalued or overvalued at current price.

Bonne chance!!!

Another long term high flyer in the making. Once all NASA approvals are sorted and tourist space flights commence, $SPCE price would likely skyrocket.

OakPearl:
If SPCE can hold strong at $25 this week, it will be a reasonably strong sign for an upward rally.

Well done, bro. Best to keep buying on price dips and accumulating Afolabi units until one gets to investment target.

OakPearl:
I have 8 out of the 12 on that list and hope to add the rest and build them up going forward.

Am so long on NIO, no matter how low they downgrade, am only going to use it to my advantage and buy more.

Warren Buffett once said those words in my signature.

Penny Stock Alert!!!
Acorda Therapeutics ($ACOR) has surged about 10.5% since market opened today after it was granted patent on methods invented "for cardiomyocyte treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid".

This was a good but risky bet for day trading. Went in on huge volumes at $0.74 and jumped out at $0.81. JIJO (jump in & jump out) trading for me on this one.
Not a recommendation to buy. DD required as usual.

Bonne chance!!!

Seriously eyeing Ericsson ($ERIC) based on recent news of the many 5G communication deals they are securing and the fact that Huawei has been fenced off the UK and US 5G markets. $ERIC and Nokia should benefit from Huawei's potential loss.

$OPKO already performing wonders today. It is a medical testing and medication company, which has inked deals with NFL, NBA and MLS to test for Covid-19. Share price surged up 27% in few hours of trading due to market reaction to above news. Let's see if it sustains this run. Got in at $5 and now $6.28.
As always, DD is required.

Bonne chance!!!

Nice one. That's why i like the NYSE, Nasdaq et al. News, whether positive or negative tends to impact share prices.

arduino:
NBEV!!!!

More than 160% already just because of merger.

The E-commerce giant, Alibaba ($BABA) seems to present great opportunities at current price ($254.81) or below. News filtering out today shows that $BABA's online payments subsidiary, the ANT Group is coming out on dual IPO to be listed in both the Shanghai and Hong Kong exchanges. It will be the biggest IPO globally in 2020 and the 3rd biggest IPO ever, behind both $BABA (no.2) and Saudi Aramco (no. 1).

The ANT Group is currently valued at over $150 Billion USD, which clearly indicates that it is bigger than some Wall Street Banks and guess what, Mr. Jack Ma, through $BABA owns a third (33%) of ANT shares, which should impact positvely on $BABA's earnings, as long as Mr. Market recognizes this.
As always, DD is required before making any decision to invest or not.

Bonne chance!!!

Great stocks to buy and hold long term, regardless of the very steep share prices. Excellent call on $NIO, in spite of the recent price downgrade to about $7 by Goldman Sacks (GS) analyst. China has the fastest growing and largest electric vehicle (EV) market in the world and $NIO should come good soon. I'm long on this one and some others on this list.

Feelers from market insiders show that GS sold 'calls' and for them to buy back the $NIO shares cheap, they had to downgrade, which basically made $NIO calls expire worthless. This scare tactics made small retail investors sell off their shares. It should be noted that big Market Makers (MM) and Brokerage firms also trade in the same markets as us, the retail investors and would go to any length to buy any shares of coy they want at relatively cheaper prices.

OakPearl:
Here are stocks I consider almost very nearly sure bets in the mid to long term.

Consideration has been given for both covid and post covid eras, so all that is required is to look for comfortable entry prices and make patience your pillow.

SQ $128.84
PTON $64.74
FSLY $84.87
SPOT $291.52
OSTK $53.49
MSFT $212.07
APPLE $393.55
NVDA $420.65
NIO $12.82
PYPL $179.23
NIU $19.47
TDOC $227.46

At first glance, you will be tempted to think they are too expensive.
But these stocks still have more gas to run and will make you sure money.

I will bookmark this for review by December 2020.

You are absolutely right. $AZN advised thay they would provide the vaccines 'at cost' to ensure that the richer nations do not hijack the purchase and distribution to only their citizens, thereby leaving out poorer countries that can’t afford to pay for the expensive vaccines. The Bill and Melinda Gates foundation and the WHO are funding the initiative to provide approved $AZN vaccine to poorer nations.

Also, some countries like Russia have deals with $AZN, while a private Indian coy (the Serum Institute of India) has a licensing arrangement with $AZN for them to produce 1 billion doses for India with the initial 400 million doses expected to be delivered by 2020 YE. At this time, $AZN has not advised the cost/value of those separate deals with the likes of Russia, SI of India and others.

OvaSabi1:
It appears that the AZN in the London stock exchange gained. Another thing I saw was that AZN would provide the drugs at cost. Not at a profit. Maybe this is what the market is reacting to? This is in conflict with what I read earlier that there was a partnership with an NGO who would accept it at the normal selling price, but distribute at a discount.

It's out of place for $AZN's share price to fall about 3% during early trading hours today, after such an encouraging vaccine preliminary trial result. My take is that the market probably expected a more definitive statement that the vaccine trial was over, vaccine would be mass-produced and deployed to enable full reopening of the stalling US economy. Anyways, this is initial market reaction and could change in the upcoming trading days, once traders assimilate more detailed analysis of $AZN's vaccine trial result.

To summarize, the preliminary result released today from large early-stage human trial indicate that $AZN's vaccine produced both 'antibodies' and killer 'T-cells' (i.e. double protection), which lasted about two months, and fought the covid-19 infection with minimal side effects. Recall that all preliminary vaccines from #AZN's competitors, showed that they only produced 'antibodies', without producing the killer 'T-cells'.

OvaSabi1:
I don't understand the magic happening with AZN. After publication of promising results, it appears to be going down? Please can somebody help us shalaye?

From Technical Analysis (TA), $BNED price uptrend in the last few trading days show that the stock has broken out and approaching its 200-day simple moving average (sma) of $2.92. Hence, while the current price or below signifies a good entry price, share price is up 1.99% at $2.56 in after hours trading of Friday, July 17 and doesn't indicate a dip on Monday, July 20. Same applies to $SPCE where I don't see the potential pullback yet because of euphoria created by the announcement of its new CEO. $SPCE is up 1.87% at $24.50 in after hours of Friday, July 17.

My picks for next week include $AZN, $NIO (price looking attractive due to sell offs), $BOXL, $BNED, $ZVO, $APHA, $GOCO (health insurance), $INO, $IHRT, $CHMA and $DVAX (currently developing and testing vaccines for cancer, Asthma, Hepatitis B and Influenza).
As always, due diligence is required before investing in any stock.

Bonne chance!!!

vibesdot001:
Distinguished members please any ideas if SPCE and BNED will have a considerable dip on Monday for a good entry. Kindly recommend good tickers for next week.